should we embrace hypofractionated radiotherapy for cervical cancer? a technical note on management during the covid-19 pandemic. ¬© 2020 Elsevier B.V.Cervical cancer is a deadly disease and the COVID-19 pandemic has the potential to further impact its lethality. Hypofractionated radiotherapy could mitigate this impact, however robust data in cervical cancer setting still is lacking. Information provided here could help institutions in reducing radiotherapy fractions for cervical cancer patients.